OR-1896

SynDRA canonical compound SYN0260991 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	PDE3A \| SMPD1
Mechanism of action	phosphodiesterase inhibitor
Indication	congestive heart failure
Disease area	cardiology

Cross-references

PubChem CID: 9816296
ChEMBL: CHEMBL340785
ChEBI: 178014

Synonyms

IKC90B19NV
RefChem:928248
DTXCID301516300
MFCD09952125
UNII-IKC90B19NV
dihydropyridazinone 6a
orb1708975
SCHEMBL3723997
BDBM15298
CHEBI:178014
AKOS030565966
MS-23469
HY-135746
CS-0113919
G13652
T12315
BRD-K86283245-001-01-7
N-[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]acetamide

Look up OR-1896 in the interactive SynDRA portal →